Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andersen

Showing results (851-860 of 1,297) with videos related to

Pageof 130
Sort By:
Contemporary Clinical Trials|April 16, 2026
Effects of supervised progressive resistance training on corticospinal excitability in persons with multiple sclerosis: A randomized controlled trial protocol for the NEXIMS studyTherese M Andersen, Hjalte Riis, Hatice Tankisi, et al.
Annals of Internal Medicine|October 17, 2001
Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected personsM H Katz, W E Cunningham, J A Fleishman, et al.
Human Mutation|November 21, 2002
D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotypeMatthew J Parton, Wendy Broom, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 26, 2001
The geographical and ethnic distribution of the D90A CuZn-SOD mutation in the Russian FederationP M Andersen, V A Spitsyn, S V Makarov, et al.
Informatics for Health & Social Care|February 26, 2021
Development of an internet-delivered program and platform for the treatment of depression and anxiety in patients with ischemic heart disease in eMindYourHeartThomas Schmidt, Robin Kok, Christina M Andersen, et al.
Neuroscience Letters|September 22, 2005
Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypesWendy J Broom, Carsten Russ, Peter C Sapp, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1991
Platelet alpha-2 adrenoreceptor activity pre-treatment and post-treatment in major depressive disorder with melancholiaS C Bhatia, H H Hsieh, K A Theesen, et al.
Theriogenology|November 17, 2023
Evaluation of later timepoints for fixed-time artificial insemination of beef heifers and cows when using sex-sorted semenGenevieve M VanWye, Carson M Andersen, Emily G Smith, et al.
BJU International|February 27, 2023
Standardized prostate cancer incidence and mortality rates following initial non-malignant biopsy resultHein V Stroomberg, Marc C M Andersen, John Thomas Helgstrand, et al.
European Journal of Endocrinology|May 11, 2004
Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiencyB Abrahamsen, T L Nielsen, J Hangaard, et al.
Pageof 130

Showing results (851-860 of 1,297) with videos related to

Sort By:
Pageof 130
Contemporary Clinical Trials|April 16, 2026
Effects of supervised progressive resistance training on corticospinal excitability in persons with multiple sclerosis: A randomized controlled trial protocol for the NEXIMS studyTherese M Andersen, Hjalte Riis, Hatice Tankisi, et al.
Annals of Internal Medicine|October 17, 2001
Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected personsM H Katz, W E Cunningham, J A Fleishman, et al.
Human Mutation|November 21, 2002
D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotypeMatthew J Parton, Wendy Broom, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 26, 2001
The geographical and ethnic distribution of the D90A CuZn-SOD mutation in the Russian FederationP M Andersen, V A Spitsyn, S V Makarov, et al.
Informatics for Health & Social Care|February 26, 2021
Development of an internet-delivered program and platform for the treatment of depression and anxiety in patients with ischemic heart disease in eMindYourHeartThomas Schmidt, Robin Kok, Christina M Andersen, et al.
Neuroscience Letters|September 22, 2005
Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypesWendy J Broom, Carsten Russ, Peter C Sapp, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1991
Platelet alpha-2 adrenoreceptor activity pre-treatment and post-treatment in major depressive disorder with melancholiaS C Bhatia, H H Hsieh, K A Theesen, et al.
Theriogenology|November 17, 2023
Evaluation of later timepoints for fixed-time artificial insemination of beef heifers and cows when using sex-sorted semenGenevieve M VanWye, Carson M Andersen, Emily G Smith, et al.
BJU International|February 27, 2023
Standardized prostate cancer incidence and mortality rates following initial non-malignant biopsy resultHein V Stroomberg, Marc C M Andersen, John Thomas Helgstrand, et al.
European Journal of Endocrinology|May 11, 2004
Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiencyB Abrahamsen, T L Nielsen, J Hangaard, et al.
Pageof 130